Abrdn Healthcare Investors Fundamental Analysis (NYSE: HQH)
Abrdn Healthcare Investors Fundamental Analysis (NYSE: HQH)
Abrdn Healthcare Investors (NYSE: HQH) shows moderate financial fundamentals with a PE ratio of 12.79, profit margin of 98.80%, and ROE of 9.16%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze HQH's fundamental strength across five key dimensions:
Efficiency Score
WeakHQH struggles to generate sufficient returns from assets.
Valuation Score
ExcellentHQH trades at attractive valuation levels.
Growth Score
ModerateHQH shows steady but slowing expansion.
Financial Health Score
ExcellentHQH maintains a strong and stable balance sheet.
Profitability Score
WeakHQH struggles to sustain strong margins.
Key Financial Metrics
Is HQH Expensive or Cheap?
P/E Ratio
HQH trades at 12.79 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HQH's PEG of 0.09 indicates potential undervaluation.
Price to Book
The market values Abrdn Healthcare Investors at 1.15 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 13.65 times EBITDA. This signals the market has high growth expectations.
How Well Does HQH Make Money?
Net Profit Margin
For every $100 in sales, Abrdn Healthcare Investors keeps $98.80 as profit after all expenses.
Operating Margin
Core operations generate 98.80 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.16 in profit for every $100 of shareholder equity.
ROA
Abrdn Healthcare Investors generates $8.99 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Abrdn Healthcare Investors generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Abrdn Healthcare Investors generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
HQH converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.79
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.15
vs 25 benchmark
P/S Ratio
Price to sales ratio
13.49
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.15
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How HQH Stacks Against Its Sector Peers
| Metric | HQH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.79 | 21.07 | Better (Cheaper) |
| ROE | 9.16% | 647.00% | Weak |
| Net Margin | 98.80% | -1593.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.90 | Strong (Low Leverage) |
| Current Ratio | 2.15 | 911.99 | Strong Liquidity |
| ROA | 8.99% | -578.00% (disorted) | Weak |
HQH outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Abrdn Healthcare Investors's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical